Applied Biosciences Corp banner

Applied Biosciences Corp
OTC:APPB

Watchlist Manager
Applied Biosciences Corp Logo
Applied Biosciences Corp
OTC:APPB
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $1.4k

Relative Value

APPB latest financial reports are more than 3 years old.
APPB doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of APPB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

APPB Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

APPB Competitors Multiples
Applied Biosciences Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Applied Biosciences Corp
OTC:APPB
1.4k USD 0 -0 -0.2 -0.2
US
Eli Lilly and Co
NYSE:LLY
866.9B USD 13.3 42 28.4 30.3
US
Johnson & Johnson
NYSE:JNJ
572.1B USD 6.1 21.3 14.8 18.2
CH
Roche Holding AG
SIX:ROG
250.6B CHF 4.1 19.5 11.5 13
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP 5 28.6 15.9 22.4
CH
Novartis AG
SIX:NOVN
225.9B CHF 5.2 20.8 12.9 16.5
US
Merck & Co Inc
NYSE:MRK
282.6B USD 4.3 15.5 9.6 11.7
IE
Endo International PLC
LSE:0Y5F
240.1B USD 103.6 -82.1 380.1 953.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.4 10.3 7.7 9
US
Pfizer Inc
NYSE:PFE
155.9B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
117B USD 2.4 16.6 7 8.7
P/E Multiple
Earnings Growth PEG
US
Applied Biosciences Corp
OTC:APPB
Average P/E: 21.6
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.3
7%
3
CH
Roche Holding AG
SIX:ROG
19.5
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
28.6
26%
1.1
CH
Novartis AG
SIX:NOVN
20.8
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.5
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -82.1 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
1%
10.3
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.6
16%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Applied Biosciences Corp
OTC:APPB
Average EV/EBITDA: 49.6
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.4
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.8
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.5
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
15.9
13%
1.2
CH
Novartis AG
SIX:NOVN
12.9
5%
2.6
US
Merck & Co Inc
NYSE:MRK
9.6
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
380.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.7
1%
7.7
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Applied Biosciences Corp
OTC:APPB
Average EV/EBIT: 109.3
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.3
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.2
7%
2.6
CH
Roche Holding AG
SIX:ROG
13
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
22.4
21%
1.1
CH
Novartis AG
SIX:NOVN
16.5
9%
1.8
US
Merck & Co Inc
NYSE:MRK
11.7
6%
2
IE
E
Endo International PLC
LSE:0Y5F
953.2
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9
3%
3
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.7
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett